A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations
Atavistik Bio, Inc
Atavistik Bio, Inc
Genmab
Elevation Oncology
Labcorp Corporation of America Holdings, Inc
Genmab
Kineta Inc.
Exact Sciences Corporation
SpeciCare
ImmunoFrontier, Inc.